Eplontersen: a promising breakthrough in treating hereditary transthyretin amyloidosis-related polyneuropathy

Ann Med Surg (Lond). 2024 Jun 26;86(8):4336-4337. doi: 10.1097/MS9.0000000000002330. eCollection 2024 Aug.
No abstract available

Publication types

  • Editorial